A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity

ABSTRACTMany patients of all ages have multiple conditions, yet clinicians often lack explicit guidance on how to approach clinical decision-making for such people. Most recommendations from clinical practice guidelines (CPGs) focus on the management of single diseases, and may be harmful or impractical for patients with multimorbidity. A major barrier to the development of guidance for people with multimorbidity stems from the fact that the evidence underlying CPGs derives from studies predominantly focused on the management of a single disease. In this paper, the investigators from the Improving Guidelines for Multimorbid Patients Study Group present consensus-based recommendations for guideline developers to make guidelines more useful for the care of people with multimorbidity. In an iterative process informed by review of key literature and experience, we drafted a list of issues and possible approaches for addressing important coexisting conditions in each step of the guideline development process, with a focus on considering relevant interactions between the conditions, their treatments and their outcomes. The recommended approaches address consideration of coexisting conditions at all major steps in CPG development, from nominating and scoping the topic, commissioning the work group, refining key questions, ranking importance of outcomes, conducting systematic reviews, assessing quality of evidence and applicability, summarizing benefits and harms, to formulating recommendations and grading their strength. The list of issues and recommendations was reviewed and refined iteratively by stakeholders. This framework acknowledges the challenges faced by CPG developers who must make complex judgments in the absence of high-quality or direct evidence. These recommendations require validation through implementation, evaluation and refinement.

[1]  F. Hughes,et al.  Quality of evidence , 2013, BDJ.

[2]  Qian-Li Xue,et al.  Difficulty Assisting with Health Care Tasks Among Caregivers of Multimorbid Older Adults , 2011, Journal of General Internal Medicine.

[3]  K. Uhlig,et al.  Guidelines for the older adult with CKD. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  S. Kaplan,et al.  Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes , 2009, Annals of Internal Medicine.

[5]  Gerald Gartlehner,et al.  [GRADE guidelines: 8. Rating the quality of evidence - indirectness]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[6]  Elvy Ickowicz Guidelines for Improving the Care of the Older Person with Diabetes Mellitus , 2003 .

[7]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[8]  M. Puhan,et al.  High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease , 2011, BMC medicine.

[9]  D. Singer,et al.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[10]  P. Parfrey,et al.  Preventing Nephropathy Induced by Contrast Medium , 2006 .

[11]  A. Wu,et al.  Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. , 2005, JAMA.

[12]  Gordon H Guyatt,et al.  Credibility of claims of subgroup effects in randomised controlled trials: systematic review , 2012, BMJ : British Medical Journal.

[13]  Diana B Petitti,et al.  Update on the Methods of the U.S. Preventive Services Task Force: Insufficient Evidence , 2009, Annals of Internal Medicine.

[14]  A. Macleod,et al.  Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD) , 2009 .

[15]  J. Kremer,et al.  Feasibility of a Wiki as a Participatory Tool for Patients in Clinical Guideline Development , 2012, Journal of medical Internet research.

[16]  G. Guyatt,et al.  The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution , 2010, Annals of Internal Medicine.

[17]  B. Thiers,et al.  Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals: A Systematic Sampling Review , 2008 .

[18]  David M Kent,et al.  Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.

[19]  Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. , 2011, Journal of clinical epidemiology.

[20]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[21]  David M Kent,et al.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. , 2007, JAMA.

[22]  Ravi Varadhan,et al.  Multimorbidity and Evidence Generation , 2014, Journal of General Internal Medicine.

[23]  K. Tashima,et al.  Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  F. Légaré,et al.  Patient and Public Involvement in Clinical Practice Guidelines , 2011, Medical decision making : an international journal of the Society for Medical Decision Making.

[25]  Paul E. Johnson,et al.  Values of Older Adults Related to Primary and Secondary Prevention , 2011 .

[26]  Sandy S Chang,et al.  Contribution of Multiple Chronic Conditions to Universal Health Outcomes , 2011, Journal of the American Geriatrics Society.

[27]  Gordon H Guyatt,et al.  GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS , 2022 .

[28]  J. Guralnik,et al.  Patterns of functional decline at the end of life. , 2003, JAMA.

[29]  B. Yawn,et al.  How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. , 2012, Proceedings of the American Thoracic Society.

[30]  K. Covinsky,et al.  Towards a combined prognostic index for survival in HIV infection: the role of ‘non‐HIV’ biomarkers , 2010, HIV medicine.

[31]  M. Puhan,et al.  Informing Evidence-Based Decision-Making for Patients with Comorbidity: Availability of Necessary Information in Clinical Trials for Chronic Diseases , 2012, PloS one.

[32]  M. Tinetti,et al.  Potential pitfalls of disease-specific guidelines for patients with multiple conditions. , 2004, The New England journal of medicine.

[33]  Michael K Gould,et al.  An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. , 2006, American journal of respiratory and critical care medicine.

[34]  P. Parfrey,et al.  Clinical practice. Preventing nephropathy induced by contrast medium. , 2006, The New England journal of medicine.

[35]  G. Guyatt,et al.  Comparing the USPSTF and GRADE Approaches to Recommendations , 2009, Annals of Internal Medicine.

[36]  Therese Miller,et al.  How to Read the New Recommendation Statement: Methods Update from the U.S. Preventive Services Task Force , 2007, Annals of Internal Medicine.

[37]  Kdoqi KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[38]  Douglas K Owens,et al.  Grading the Strength of a Body of Evidence When Comparing Medical Interventions , 2009 .

[39]  G. Guyatt,et al.  Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[40]  T. Trikalinos,et al.  Addressing Multimorbidity in Evidence Integration and Synthesis , 2014, Journal of General Internal Medicine.

[41]  Mark S Roberts,et al.  A framework for tailoring clinical guidelines to comorbidity at the point of care. , 2007, Archives of internal medicine.

[42]  Douglas K Owens,et al.  AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program. , 2010, Journal of clinical epidemiology.

[43]  Tracy A Wolff,et al.  Reconsidering the Approach to Prevention Recommendations for Older Adults , 2010, Annals of Internal Medicine.

[44]  Ameen Abu-Hanna,et al.  Characterizing Predictive Models of Mortality for Older Adults and Their Validation for Use in Clinical Practice , 2011, Journal of the American Geriatrics Society.

[45]  Cathy Schoen,et al.  Toward higher-performance health systems: adults' health care experiences in seven countries, 2007. , 2007, Health affairs.

[46]  A. Ucci,et al.  Rapidly progressive glomerulonephritis after immunotherapy for cancer. , 1995, Journal of the American Society of Nephrology : JASN.

[47]  S. Galea,et al.  Sexual Violence and Mental Health Symptoms Among National Guard and Reserve Soldiers , 2013, Journal of General Internal Medicine.

[48]  Gordon H Guyatt,et al.  Executive Summary Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2012 .

[49]  Paolo Prandoni,et al.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[50]  David M. Kent,et al.  Evidence-Based Medicine and the Hard Problem of Multimorbidity , 2014, Journal of general internal medicine.

[51]  William F. Lawrence,et al.  Chapter 10: Deciding Whether to Complement a Systematic Review of Medical Tests with Decision Modeling , 2012, Journal of General Internal Medicine.

[52]  Gert P. Westert,et al.  Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based Guidelines , 2011, PloS one.

[53]  Donna M. Zulman,et al.  Examining the Evidence: A Systematic Review of the Inclusion and Analysis of Older Adults in Randomized Controlled Trials , 2011, Journal of General Internal Medicine.

[54]  Mara A Schonberg,et al.  Prognostic indices for older adults: a systematic review. , 2012, JAMA.

[55]  Nathaniel Clark,et al.  Diabetes in Older Adults , 2012, Diabetes Care.

[56]  Amy C. Justice,et al.  The Payoff Time: A Flexible Framework to Help Clinicians Decide When Patients With Comorbid Disease are not Likely to Benefit From Practice Guidelines , 2009, Medical care.

[57]  F. Pouwer,et al.  Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis , 2010, Diabetologia.